Panelists discuss how GLP-1 therapies show dual metabolic and hepatic benefits, redefining MASH management. Stay ahead of ...
Access to and trust in the healthcare system are deeply shaped by colonialism. Research on Canadian health care systems from ...
Phase 1 Study in Non-Small Cell Lung Cancer Combined Reqorsa® Gene Therapy with Tagrisso® AUSTIN, Texas, Nov. 24, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or ...
The healthcare industry presents a wealth of opportunities for investors to generate notable portfolio returns over decades.
Dermatologists’ growing interest in training comes amid broader growth in integrative medicine — and uncertainties about ...
Seniors are the fastest-growing homeless population across the nation. Now, some shelters are trying to make it easier to accommodate the elderly.
Morning Overview on MSN
Killing ‘zombie cells’ in vessels may unlock diabetes care
Scientists are closing in on a surprising new way to tackle diabetes: hunting down “zombie cells” that clog blood vessels and fat tissue and quietly sabotage metabolism. Instead of only trying to push ...
Objectives To identify caregiver burden profiles among informal caregivers of children and adolescents with type 1 diabetes and explore associated factors. Design A multicentre cross-sectional survey ...
In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events ...
New federal rules will require more than 18 million Medicaid enrollees nationwide to show they’re working, volunteering, or ...
A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results